Kanał

CMRA

Comera Life Sciences Holdings, Inc.

CMRA · OTC

$0.00 +0.00% (+$0.00)

Piotroski F-Score Weak

2/9

Valuation

N/A

EV/EBITDA N/A

P/S N/A

P/B N/A

Growth

N/A

Rev. growth N/A

FCF growth N/A

Book val. growth N/A

Profitability

N/A

Net margin N/A

Op. margin N/A

FCF margin N/A

Quality

N/A

ROE N/A

ROA N/A

Asset turnover N/A

Debt

N/A

Current ratio N/A

Int. coverage N/A

Net debt/EBITDA N/A

Stability

74 /100

Stable

Beta 1.11x

EPS volatility N/A

Profitable years N/A

Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej

Zapytaj StockBota o CMRA

Online

O spółce

Comera Life Sciences Holdings, Inc. (CLSH) is a biotechnology company specializing in the research and development of therapeutic products aimed at improving human health. With a passion for innovation and scientific advancement, CLSH strives to find new ways of treating and preventing various diseases. Their expert team works on discovering biomarkers and therapeutic targets that can provide new perspectives in medicine. The company is known for its commitment to scientific excellence and ethical standards in research. Comera Life Sciences Holdings, Inc. (CLSH) shares could be suitable for investors interested in the biotechnology sector and supporting innovations aimed at enhancing human health.

Opis nie jest jeszcze dostępny w Twoim języku, więc tekst jest po angielsku.

Sector

Healthcare

Industry

Biotechnology

CEO

Michael G. Campbell

Employees

Headquarters

Woburn

⌘ K

StockBot Live

Sytuacja rynkowa Wall Street

Wall Street spada po podwyżce stóp przez Fed

S&P 500 -0.45% i Nasdaq -0.78% oddały wczesne zyski po podwyżce stóp Fed w celu walki z inflacją.

Zapytaj o to

StockBot zna 80,000+ akcji na całym świecie